title: Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II.
abstract: The effect of biosynthetic human insulin-like growth factor I (IGF-I) and IGF-II on the in vitro growth of human marrow myeloid progenitors in the presence of recombinant human granulocyte colony stimulating factor (rhG-CSF), granulocyte-macrophage CSF (rhGM-CSF), or interleukin-3 (rhIL-3), was investigated. IGF-I and IGF-II similarly enhanced the growth of myeloid progenitors in cultures stimulated with any of the above hemopoietic regulators. Analysis of colony composition showed an increase in the numbers of granulocyte colonies, but no alteration in the numbers of macrophage or granulocyte/macrophage colonies. IGF-I induced an increase of 62 +/- 16%, 84 +/- 13%, and 107 +/- 18% in granulocyte colony numbers in the presence of G-CSF, GM-CSF, or IL-3, respectively. The values for IGF-II were 66 +/- 13%, 96 +/- 12%, and 91 +/- 12%. Similar enhancement of myeloid colony formation by both peptides was also detected in G-CSF and GM-CSF-stimulated cultures of marrow cells that had been depleted of accessory cells, while neither peptide exerted any effect in the presence of IL-3 in such cultures. The growth-promoting effects of IGF-I and IGF-II were completely abrogated by monoclonal antibodies directed against the IGF-I (Type I) membrane receptor. IGF-I and IGF-II thus appear to exert their effects on human marrow myeloid progenitors via a direct mechanism involving the Type I receptor.
authors.affiliation: Haemopoiesis Unit, Technion Faculty of Medicine, Haifa, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Merchav
authors.forename: M
authors.initials: M
authors.lastname: Lake
authors.forename: A
authors.initials: A
authors.lastname: Skottner
mesh_terms: D000906:Antibodies / Q000276:immunology; D000938:Antigen-Presenting Cells / Q000502:physiology; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D006098:Granulocytes / Q000166:cytology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D007335:Insulin-Like Growth Factor II / Q000494:pharmacology*; D008264:Macrophages / Q000166:cytology; D017526:Receptor, IGF Type 1 / Q000276:immunology; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects
chemical_list: D000906:Antibodies; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D017526:Receptor, IGF Type 1